Burnham Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
BIT
BFA
Burnham Asset Management's BMY Position: Q2 2016 in Review
Burnham Asset Management increased its Bristol-Myers Squibb (BMY) stake by 108% in Q2 2016, buying an estimated $3.56M and bringing the position to 97,041 shares worth $7.14M. The position accounts for 1.99% of the portfolio, ranked #10.
Burnham Asset Management first reported a position in BMY in Q2 2013 and has held it in 13 quarters since. 1,576 funds tracked by Wall St. Rank hold BMY as of Q2 2016.
- Burnham Asset Management held 97,041 shares of Bristol-Myers Squibb worth $7.14M as of Q2 2016.
- Burnham Asset Management bought 50,367 Bristol-Myers Squibb shares in Q2 2016, an estimated $3.56M.
- Bristol-Myers Squibb made up 1.99% of Burnham Asset Management's portfolio in Q2 2016, its #10 holding.
- Burnham Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 13 quarters since.
- 1,576 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2016.
Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.